Log-in
E-Mail
Passwort
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Neukunde
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

MarketScreener Homepage  >  Aktien  >  Euronext Paris  >  Guerbet    GBT   FR0000032526

GUERBET (GBT)
Meine letzten Aufrufe
Populärste Aktien
  Report  
ÜbersichtKurseChartsNewsAnalysenTermineUnternehmenFundamentaldatenAnalystenschätzungenRevisionen 
OFFRE
Kurzporträt
Logo Guerbet
Engages in research, development and production of X-Rays and its by products

Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging.

The company products portfolio includes diagnostic imaging, and interventional imaging.

It operates through the following segments: Magnetic Resonance Imaging, X-ray Imaging, Interventional Radiology & Theranostics, and Imaging Solutions & Services.

The company was founded by André Guerbet on July 16, 1926 and is headquartered in Paris, France.

Mitarbeiteranzahl : 2 762 Personen.
Verkäufe nach Geschäftsbereichen
20162017Delta
EUR (in Millionen)%EUR (in Millionen)%
X- Rays375,4748.4%376,1246.6% +0.17%
Magnetic Resonance Imaging246,7031.8%272,0033.7% +10.26%
Delivery Systems and Services76,809.9%79,909.9% +4.04%
IRT55,867.2%56,507% +1.15%
Other21,722.8%22,602.8% +4.04%
Verkäufe nach Regionen
20162017Delta
EUR (in Millionen)%EUR (in Millionen)%
Other Markets402,9351.9%432,4153.6% +7.32%
European Markets372,8548.1%374,7146.4% +0.5%
Vorstände
Name AlterSeitTitel
Yves L'Epine, MD592011Chief Executive Officer & Non-Independent Director
Marie-Claire Janailhac-Fritsch632011Chairman
Jean-François Le Martret--Chief Financial Officer
Claire Corot--Senior Vice President-Research & Innovation
Pierre Desche--SVP-Development, Medical & Regulatory Affairs
Jean-François Blanc--Vice President-Technical Operations
Marion Barbier602011Non-Independent Director
Claire Massiot-Jouault572013Non-Independent Director
Mark Fouquet592014Non-Independent Director
Didier Izabel632014Independent Director
Aktien
Vote MengeFloatKonzerneigene AktienTotal Float
Aktie A 1 12 563 358 5 259 044 41.9% 20 428 0.2% 41.9%
Aktionäre
NameAktien%
Guerbet Family 7 004 209 55,8%
Norges Bank Investment Management 360 911 2,87%
Oddo BHF Asset Management SAS 355 313 2,83%
Amundi Asset Management SA (Investment Management) 161 199 1,28%
Financière de l'Échiquier SA 147 112 1,17%
The Vanguard Group, Inc. 128 976 1,03%
Dimensional Fund Advisors LP 112 358 0,89%
Wasatch Advisors, Inc. 100 000 0,80%
Ennismore Fund Management Ltd. 94 957 0,76%
Amplegest SAS 90 206 0,72%
Holdings
NameAktien%Wert
Guerbet (GBT) 19 4280,15%1 261 330 USD
Börsenplätze und Indizes
- Eligible PEA / SRD : JA / JA
- Euronext Paris
- Compartiment B
- CAC All Shares / CAC All-Tradable, CAC Mid Small, CAC PME, CAC Small, EnterNext© PEA-PME 150, PEA, PEA-PME
Börsen Codes
- Bloomberg Code :  GBT:FP
- Reuters Code :  GRBT.PA
- Datastream Code :  F:GUER
Unternehmenskontakt
Guerbet
15 Rue des Vanesses
FR-93420 Villepinte
Frankreich

Telefon : +33 (0)1 45 91 50 00
Fax : +33 (0)1 45 91 51 99
Internet : http://www.guerbet.com
Branche Diagnostic & Testing Substances Manufacturers
01.01.Marktkap. (M$)
GUERBET-28.12%842
JOHNSON & JOHNSON2.26%376 847
PFIZER21.29%257 522
NOVARTIS-0.63%217 697
ROCHE HOLDING LTD.-5.48%209 212
MERCK AND COMPANY26.36%188 241
ABBVIE-3.40%141 463
AMGEN17.94%134 121
ABBOTT LABORATORIES25.18%125 329
ELI LILLY AND COMPANY25.02%113 402
SANOFI3.69%108 559
BRISTOL-MYERS SQUIBB COMPANY1.58%100 507
GLAXOSMITHKLINE15.15%98 990
ASTRAZENECA10.72%93 622
NOVO NORDISK A/S-10.07%90 566
BAYER-25.23%83 392
BIOGEN8.93%69 905
CSL LIMITED46.58%67 417
ALLERGAN PLC16.95%63 809
CELGENE CORPORATION-15.94%61 586
SHIRE17.15%53 768
Verbindungen : Guerbet
Calenzane SAS
Mgf Easybike SAS
ABAREM
Abalux
Institut Français Des Administrateurs
LMP SARL
Bird & Bird LLP
Terranere SAS
Paris Bar Association
Xelos SAS
Association Des Médiateurs Européens
MGF SAS
La Residence de la Ferme De Croisil
Axys Finance SARL
Simpl-Fi SARL
Financière Des Pins SARL
© 2018 People , Fundamentals and Ownership
© 2018 Cofisem